Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients

Дата публикации: 11-07-2026 14:00:04

A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research published in the July issue of The Journal of Nuclear Medicine. Findings from the repeat PSMA scans, which included both local and distant disease, resulted in a change in management for nearly 50% of these patients.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	MRI scans improve prostate cancer diagnosis in screening trial	2	7	22-08-2023
2	Precision therapy for metastatic prostate cancer improves survival	2	7	20-08-2024
3	Promising new options for treating aggressive prostate cancer	7	8	18-10-2023
4	Neue Doppeltherapie macht Hoffnung: 20 Prozent weniger Metastasen bei aggressivem Prostatakrebs	7	8	03-07-2026
5	Diagnostic Accuracy of PET Imaging for Lymph Node Detection in Breast cancer patients undergoing Upfront Surgery: A Single-Institution Analysis of Breast Cancer Patients [version 3; peer review: 2 approved]	0	7	18-06-2026
6	Researchers discover new form of hereditary prostate cancer	5	7	09-07-2026
7	В Челябинске внедрена новая таргетная терапия для борьбы с раком простаты	5	7	27-06-2026
8	Breakthrough for patients with pancreatic cancer as doctors develop new blood test that can pick up 'residue cells' of the 'silent' disease that killed Alan Rickman	8	7	30-06-2026
9	В Москве внедрили новую методику диагностики рака предстательной железы	0	0	28-08-2020
10	Mezigdomide-Carfilzomib-Dexamethasone Prolongs PFS Compared with Carfilzomib-Dexamethasone at First Relapse in Patients with Relapsed Or Refractory Multiple Myeloma	0	5	09-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 2. Информативность: 7. Источник: medicalxpress.com.